Jon Medved, a prominent Israeli venture capitalist, recently shared with TechCrunch how the health technologies he once supported are now playing a crucial role in improving his own quality of life. Diagnosed with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, Medved’s personal experience underscores the importance of advancements in health tech.
ALS is a neurodegenerative disease that affects motor neurons, gradually leading to loss of muscle control and impacting essential functions like walking, talking, and breathing. Medved, a key figure in Israel’s startup ecosystem and the founder of OurCrowd, is known for his contributions to the tech industry.
Having backed various health tech startups in the past, Medved now finds himself relying on the innovations he championed to enhance his daily life. His journey highlights the critical role of technology in addressing healthcare challenges and improving patient outcomes.
As the tech community rallies around Medved, his story serves as a reminder of the transformative power of innovation in the face of adversity.
Source: TechCrunch
Leave a Reply